lisocabtagene maraleucel,tocilizumab
roche,bms
['transform,(-transformi),(-transforme),(-transforma),(-transforms),(-transform1),(-transform 1),(-transform-1),(-transform2),(-transform 2),(-transform-2)', 'tocilizumab', 'toci', 'lymsm', 'liso-cel']
congress | #ash22 jeremy abramson, md presents data on liso-cel vs soc + salvage chemo + asct as 2l treatment in patients with r/r lbcl (transform study). liso-cel demonstrated statistically significant benefits to efs, cr rate and pfs.
#lymsm #medicalcongress 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm